These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 23729081)

  • 21. Medicare program; end-stage renal disease program; prospective reimbursement for dialysis services and approval of special purpose renal dialysis facilities--HCFA. Final rule.
    Fed Regist; 1983 May; 48(92):21254-91. PubMed ID: 10299129
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Managing anemia in for-profit dialysis chains: when ethics and business conflict.
    Coyne DW
    Semin Dial; 2009; 22(1):18-21. PubMed ID: 19250444
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The biological and economic value of oral organic iron in maintenance dialysis.
    Wish JB; Fourtner P; Ghaddar S; Moore GM
    Nephrol News Issues; 2002 Mar; 16(4):32-3, 37-9. PubMed ID: 11902060
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The impact of the bundle on lab services.
    Burney M
    Nephrol News Issues; 2011 Jul; 25(8):14-5. PubMed ID: 21877618
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cost-quality trade-offs in dialysis care: a national survey of dialysis facility administrators.
    Powe NR; Thamer M; Hwang W; Fink NE; Bass EB; Sadler JH; Levin NW
    Am J Kidney Dis; 2002 Jan; 39(1):116-26. PubMed ID: 11774110
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Past, present, and future of chronic kidney disease anemia management in the United States.
    Wish JB
    Adv Chronic Kidney Dis; 2009 Mar; 16(2):101-8. PubMed ID: 19233069
    [TBL] [Abstract][Full Text] [Related]  

  • 27. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Medicare programs; end-stage renal disease program; prospective reimbursement for dialysis services: Health Care Financing Administration. Proposed rule.
    Fed Regist; 1982 Feb; 47(30):6556-82. PubMed ID: 10298416
    [TBL] [Abstract][Full Text] [Related]  

  • 29. How to make the new conditions for coverage work in your dialysis clinic.
    Karalis M
    Nephrol News Issues; 2009 Apr; 23(4):28, 31. PubMed ID: 19437945
    [No Abstract]   [Full Text] [Related]  

  • 30. Economic corrections and the potential impact on the dialysis industry.
    Sullivan JD
    Nephrol News Issues; 2009 Jul; 23(8):14-6. PubMed ID: 19662907
    [No Abstract]   [Full Text] [Related]  

  • 31. Multidisciplinary team care for CKD-MBD. Achieving KDIGO guideline recommendations in the bundling era.
    McCann L; Hoefs M
    Nephrol News Issues; 2014 Apr; 28(4):24-6, 28, 30-2 passim. PubMed ID: 24960985
    [TBL] [Abstract][Full Text] [Related]  

  • 32. New conditions for coverage will impose a host of new requirements on dialysis clinics.
    Riley J; Pristave R; Kannensohn KJ
    Nephrol News Issues; 2005 Apr; 19(5):25-6, 28, 30. PubMed ID: 15861764
    [No Abstract]   [Full Text] [Related]  

  • 33. Prospective payment plan for ESRD care proposed.
    Med Prod Sales; 1982 Apr; 13(4):3, 104-9, 111-2 passim. PubMed ID: 10273297
    [No Abstract]   [Full Text] [Related]  

  • 34. Is the bundle leading to a tighter provider market? Key acquisition, merger mark activity in 2010-2011.
    Neumann ME
    Nephrol News Issues; 2011 Jul; 25(8):32-3. PubMed ID: 21877623
    [No Abstract]   [Full Text] [Related]  

  • 35. Cost analysis of renal replacement therapy by transplant in a system of bundled payment of dialysis.
    Rocha MJ; Ferreira S; Martins LS; Almeida M; Dias L; Pedroso S; Henriques AC; Almeida R; Cabrita A
    Clin Transplant; 2012; 26(4):529-31. PubMed ID: 22211715
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Futuristic plans for ESRD--a new bundled payment system.
    Michael M
    Nephrol News Issues; 2005 Sep; 19(10):52, 54. PubMed ID: 16187649
    [No Abstract]   [Full Text] [Related]  

  • 37. The proposed reimbursement regulation.
    Hanson K
    Nephrol Nurse; 1982; 4(3):12-6. PubMed ID: 6919761
    [No Abstract]   [Full Text] [Related]  

  • 38. 2008 Japanese Society for Dialysis Therapy: guidelines for renal anemia in chronic kidney disease.
    Tsubakihara Y; Nishi S; Akiba T; Hirakata H; Iseki K; Kubota M; Kuriyama S; Komatsu Y; Suzuki M; Nakai S; Hattori M; Babazono T; Hiramatsu M; Yamamoto H; Bessho M; Akizawa T
    Ther Apher Dial; 2010 Jun; 14(3):240-75. PubMed ID: 20609178
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Economic impact of case-mix adjusting the dialysis composite rate.
    Hirth RA; Roys EC; Wheeler JR; Messana JM; Turenne MN; Saran R; Pozniak AS; Wolfe RA
    J Am Soc Nephrol; 2005 May; 16(5):1172-6. PubMed ID: 15800122
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Appendix to dialysis centre guidelines: recommendations for the relationship between outpatient haemodialysis centres and reference hospitals. Opinions from the Outpatient Dialysis Group. Grupo de Trabajo de Hemodiálisis Extrahospitalaria.
    Berdud I; Arenas MD; Bernat A; Ramos R; Blanco A;
    Nefrologia; 2011; 31(6):664-9. PubMed ID: 22130281
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.